Mortality in HIV+ immunosuppressed adults:intensive screening is equivalent to preventive treatment

(ANRS) The STATIS trial (sponsor Inserm-ANRS) has compared two innovative strategies designed to reduce mortality in severely immunosuppressed HIV-infected adults. Coordinated by Professors Fran ç ois-Xavier Blanc (CHU de Nantes) and Serge Domoua (Programme PAC-CI, CHU de Treichville, Abidjan), the trial is being conducted in Cambodia, C ô te d'Ivoire, Uganda, and Vietnam. The results will be presented this Monday, March 5, at the Conference on Retroviruses and Opportunistic Infections held in Boston from March 4 to 7, 2018.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news